human genome cgh microarray 60-mer oligonucleotide-based microarray (Agilent technologies)
90
Structured Review
Agilent technologies
human genome cgh microarray 60-mer oligonucleotide-based microarray
Human Genome Cgh Microarray 60 Mer Oligonucleotide Based Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60-mer+oligonucleotide-based+microarray/pmc06949681-160-9-8
Average 90 stars, based on 1 article reviews
Human Genome Cgh Microarray 60 Mer Oligonucleotide Based Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60-mer+oligonucleotide-based+microarray/pmc06949681-160-9-8
Average 90 stars, based on 1 article reviews
human genome cgh microarray 60-mer oligonucleotide-based microarray - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Haploinsufficiency of NKX2-1 is likely to contribute to developmental delay involving 14q13 microdeletions Article Snippet: Chromosomal microarray analysis (CMA) was performed using an Article Title: Towards New Approaches to Evaluate Dynamic Mosaicism in Ring Chromosome 13 Syndrome Article Snippet: Whole-genome analysis was performed by means of the Article Title: Narrowing down the region responsible for 1q23.3q24.1 microdeletion by identifying the smallest deletion Article Snippet: After obtaining written informed consent from the patient’s family, we performed chromosomal microarray testing using the Control:Article Title: Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion Article Snippet: DNA concentration was measured using a NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., Waltham, MA) and high molecular weight DNA quality was verified by agarose gel electrophoresis. .. For each aCGH analysis, 2.5 μg of test genomic DNA from the patient and 2.5 μg of control DNA from a sex-matched or -mismatched healthy individual were used following the manufacturer’s protocol for the Agilent Microarray:Article Title: Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion Article Snippet: DNA concentration was measured using a NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., Waltham, MA) and high molecular weight DNA quality was verified by agarose gel electrophoresis. .. For each aCGH analysis, 2.5 μg of test genomic DNA from the patient and 2.5 μg of control DNA from a sex-matched or -mismatched healthy individual were used following the manufacturer’s protocol for the Agilent Article Title: Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases. Article Snippet: 197 Article Title: An Xq22.1q22.2 nullisomy in a male patient with severe neurological impairment. Article Snippet: 1Department of Pediatrics, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki, Japan 2Department of Neonatology, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki, Japan 3 Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan 4 Tokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan Correspondence Toshiyuki Yamamoto, M.D., Ph.D., Institute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo 162-8666, Japan.. Email: yamamoto.toshiyuki@twmu.ac.jp Funding information Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant number: 15K09631; Japan Agency for Medical Research and Development (AMED) The proteolipid protein 1 gene (PLP1) is located on chromosome Xq22.2 and is related to X-linked recessive leukoencephalopathy (Pelizaeus–Merzbacher disease: PMD).. Compared to PLP1 duplications, which are a major contributor to PMD, chromosomal deletions in this region are rare and only a few PMD patients with small deletions have been reported, suggesting that large deletions of this region would cause embryonic lethality. Article Title: A familial chromosomal complex rearrangement confirms RUNX1T1 as a causative gene for intellectual disability and suggests that 1p22.1p21.3 duplication is likely benign Article Snippet: Patient’s DNA was isolated from bone marrow and buccal swab, using QIAamp DNA mini kit (Qiagen). .. Array-CGH was performed on both samples in accordance with manufacturer’s instructions, using Agilent Article Title: Messengers of tolerance. Article Snippet: The use of immunosuppressant drugs after organ transplantation has brought great success in the field of organ transplantation with respect to short-term outcome.. However, major challenges such (i.e., limited improvement of long-term survival, immunosuppressant toxicity, infections and carcinoma), demand alternate treatment approaches that minimizes the use of immunosuppressants.. Interestingly, few studies have identified groups of transplant patients who developed operational tolerance and thereby keep their allograft without complications in absence of immunosuppressants. Hybridization:Article Title: An Xq22.1q22.2 nullisomy in a male patient with severe neurological impairment. Article Snippet: 1Department of Pediatrics, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki, Japan 2Department of Neonatology, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki, Japan 3 Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan 4 Tokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan Correspondence Toshiyuki Yamamoto, M.D., Ph.D., Institute of Medical Genetics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ward, Tokyo 162-8666, Japan.. Email: yamamoto.toshiyuki@twmu.ac.jp Funding information Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant number: 15K09631; Japan Agency for Medical Research and Development (AMED) The proteolipid protein 1 gene (PLP1) is located on chromosome Xq22.2 and is related to X-linked recessive leukoencephalopathy (Pelizaeus–Merzbacher disease: PMD).. Compared to PLP1 duplications, which are a major contributor to PMD, chromosomal deletions in this region are rare and only a few PMD patients with small deletions have been reported, suggesting that large deletions of this region would cause embryonic lethality. Purification:Article Title: Messengers of tolerance. Article Snippet: The use of immunosuppressant drugs after organ transplantation has brought great success in the field of organ transplantation with respect to short-term outcome.. However, major challenges such (i.e., limited improvement of long-term survival, immunosuppressant toxicity, infections and carcinoma), demand alternate treatment approaches that minimizes the use of immunosuppressants.. Interestingly, few studies have identified groups of transplant patients who developed operational tolerance and thereby keep their allograft without complications in absence of immunosuppressants. Quantitative Proteomics:Article Title: Messengers of tolerance. Article Snippet: The use of immunosuppressant drugs after organ transplantation has brought great success in the field of organ transplantation with respect to short-term outcome.. However, major challenges such (i.e., limited improvement of long-term survival, immunosuppressant toxicity, infections and carcinoma), demand alternate treatment approaches that minimizes the use of immunosuppressants.. Interestingly, few studies have identified groups of transplant patients who developed operational tolerance and thereby keep their allograft without complications in absence of immunosuppressants. |